Board documents
19-20 December 2017

Board Meeting 28

Starling Hotel Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Replenishment of Unitaid’s Proposal Review Committee
R2 - Adoption of the Terms of Reference of the Proposal Review Committee (PRC)
R3 - Approval of the 2018 Unitaid budget
R4 - Unitaid Commitment Policy
R5 - Fever Management Area for Intervention
R6 - Governance Working Group Extension of Mandate
R7 - Appointment of PSC and FAC members
07-08 June 2017

Board Meeting 27

Starling Hotel Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Better tools for integrated management of childhood fever
R2 - Amended Terms of Reference of the Policy and Strategy Committee
R3 - Amended Terms of Reference for the Proposal Review Committee
R4 - Unitaid 2016 Audited Financial Statements
R5 - Area for Intervention: Optimizing management of coinfections and comorbidities in people living with HIV
13-14 December 2016

Board Meeting 26

Starling hotel Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Unitaid Strategy 2017-2021
R2 - Strategy 2017-2021: Key Performance Indicators
R3 - Budget 2017
R4 - HIV Area for Intervention: “Expanding access to HIV self-testing in low- and middle-income countries”
R5 - Area for Intervention related to Intellectual Property (IP): “Supporting the use of TRIPS flexibilities”
R6 - Appointment of the Chairs and Vice-Chairs of the standing Committees of the Board
R7 - Calendar of Unitaid Board and committee meetings for 2017
R8 - Governance Working Group
22-23 June 2016

Board Meeting 25

Hôtel de Ville and French Ministry of Foreign Affairs and International Development Paris, France.

Minutes:

Resoultions:

R1 - Unitaid audited financial statements
R2 - Amended FAC terms of reference
R3 - Policy to address risk of wrongdoing
R4 - Additional staffing requirements
R5 - Strategic option reproductive, maternal, newborn and child health
R6 - MDR-TB Strategic Rotating Stockpile (SRS) project
R7 - Potential opportunity: malaria vaccine
R8 - Unitaid’s approach to intellectual property
R9 - Terms of reference for Vice-Chair and related amendments to the board operating procedures
R10 - Election of Unitaid Executive Board Vice-Chair
R11 - Election of Unitaid Executive Board Chair
16-17 March 2016

Board Meeting 24 Special Session

Starling Hotel Geneva, Switzerland.

Minutes:

Resoultions:

R1 - Tuberculosis area for intervention: better, shorter treatments for MDR-TB
R2 - Tuberculosis area for intervention: scale up of better Tuberculosis treatment for
R3 - Tuberculosis area for intervention: enabling preventive Tuberculosis treatment in high-risk groups
R4 - Development of the 2017-2021 strategy
R5 - Selection process for the Executive Board Chair
R6 - Calendar of Unitaid board meetings for 2016
04-05 November 2015

Board Meeting 23

UNAIDS building Geneva, Switzerland.

Minutes:

Resoultions:

R10 - Review of Unitaid governance documents
R9 - Calendar of Unitaid board meetings for 2016
R8 - Term of office of the vice chair
R7 - Terms of reference and procedure for selection of new board chair
R6 - Expansion of the scope of the grant to the Medicines Patent Pool (HCV and TB)
R5 - Malaria and areas for intervention: optimizing introduction of tools for the treatment of severe malaria
R4 - Malaria and areas for intervention: expanding private sector access to diagnostics testing and treatment
R3 - Malaria and areas for intervention: accelerating adoption of innovative vector control tools
R2 - Malaria and Areas for Intervention: Expanding access to preventive chemotherapy in pregnant women
R1 - 2016 Budget
23 April 2015

EB retreat

Geneva, Switzerland.

Minutes:

Resolutions :

No resolutions adopted
02-04 June 2015

Board Meeting 22

Fiocruz’ Headquarters Rio de Janeiro, Brazil.

Minutes:

Resoultions:

R8 - MDR-TB strategic rotating stockpile (SRS) project
R7 - Market intervention to accelerate uptake of new vector control tools
R6 - Area for intervention: development of better tools to diagnose HCV, in particular in case of HIV/HCV co-infection
R5 - Area for intervention: enabling scale-up of PrEP and linkage to test
R4 - Area for intervention: improvement of adult antiretroviral therapy in low and middle-income countries
R3 - Project preparation facility
R2 - New operating model
R1 - Unitaid audited financial statements
1 2 3 4 5 6

2024

January

R1-2024-e

Cost Extension for the Project “Advancing Spatial Repellents for Vector-borne Disease Control” (AEGIS)

2023

December

R23-2023-e

Calendar of Board and Committee meetings for 2024

R22-2023-e

Enabling Access – Medical Innovations For All

R21-2023-e

Mobilizing for Equitable Access

R20-2023-e

The Solidarity Project

R19-2023-e

Cost Extension for the Project “Scale Up Cervical Cancer Elimination with Secondary Prevention Strategy (SUCCESS)”

November

R18-2023-e

Additional contribution from the Republic of Korea

October

R17-2023-e

Cost Extension for the Project “Adherence Support Coalition to End TB” (ASCENT)

1 2 3 4 5 26

No posts found.